A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma

Dermatology Online Journal

Volumn 20, Issue 3, 2014, Pages

  Scheinfeld, Noah ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; DEFENSIN; IMMUNOSUPPRESSIVE AGENT; NOTCH RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; ANUS DISEASE; BUTTOCK; CANCER MORTALITY; CANCER SURVIVAL; CASE REPORT; CONSULTATION; DEBRIDEMENT; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG EFFICACY; FAMILIAL DISEASE; HUMAN; HUMAN TISSUE; INGUINAL REGION; LEG DISEASE; LETTER; MALE; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; PALLIATIVE THERAPY; PERINEUM; REOPERATION; SKIN CARCINOMA; SUPPURATIVE HIDRADENITIS; SURVIVAL TIME; ANTAGONISTS AND INHIBITORS; ANUS NEOPLASMS; CELL TRANSFORMATION; COMPLICATION; FATALITY; HIDRADENITIS SUPPURATIVA; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAPILLOMAVIRUS INFECTION; PHYSIOLOGY; SECONDARY; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; COMBINED MODALITY THERAPY; DEBRIDEMENT; DEFENSINS; FATAL OUTCOME; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFLIXIMAB; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, NOTCH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896450567     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (26)

1. Curry SS, Gaither DH, King LE Jr. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp, A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol.1981;6:673-8.
2. Quintal D, Jackson R. Aggressive squamous cell carcinoma arising in familial acne conglobata. J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):207-14.[PMID: 2936774]
3. Camisa C. Squamous cell carcinoma arising in acne conglobata. Cutis. 1984 Feb;33(2):185-7, 190.[PMID: 6230214]
4. Nunes LF, de Castro Neto AK, Vasconcelos RA, Cajaraville F, Castilho J, Rezende JF, Noguera WS. Carcinomatous degeneration of pilonidal cyst with sacrum destruction and invasion of the rectum. An Bras Dermatol. 2013 Nov-Dec;88(6 Suppl 1):59-62.[PMID: 24346881]
5. Losanoff JE, Sochaki P, Khoury N, Levi E, Salwen WA, Basson MD. Squamous cell carcinoma complicating chronic suppurative hydradenitis. Am Surg. 2011 Nov;77(11):1449-53.[PMID: 22196655]
6. Yu N, Long X, Lujan-Hernandez JR, Hassan KZ, Bai M, Wang Y, Wang X, Zhao R. Marjolin's ulcer: a preventable malignancy arising from scars. World J Surg Oncol. 2013 Dec 17;11(1):313.[PMID: 24341890]
7. The relationship between fistulas in Crohn's disease and associated carcinoma. Report of four cases and review of the literature. Church JM, Weakley FL, Fazio VW, Sebek BA, Achkar E, Carwell M. Dis Colon Rectum. 1985 May;28(5):361-6.[PMID: 3158499]
8. Lin MT, Breiner M, Fredricks S. Marjolin's ulcer occurring in hidradenitis suppurativa. Plast Reconstr Surg. 1999 Apr;103(5):1541-3.[PMID: 10190470]
9. Lavogiez C, Delaporte E, Darras-Vercambre S, Martin De Lassalle E, Castillo C, Mirabel X, Laurent F, Patenotre P, Gheit T, Talmant JC, Beylot-Barry M, Martinot V, Piette F, Aubin F, Mortier L. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology. 2010;220(2):147-53.[PMID: 20029163]
10. Verma SB. Verruca plus acrochordon: an 'over the top' skin tag. Clin Exp Dermatol. 2009 Oct;34(7):e432-3.[PMID: 19747304]
11. Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013 Jan;133(1):97-103.[PMID: 22931916]
12. Hofmann SC, Saborowski V, Lange S, Kern WV, Bruckner-Tuderman L, Rieg S. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. J Am Acad Dermatol. 2012 Jun;66(6):966-74.[PMID: 21982063]
13. Dréno B, Khammari A, Brocard A, Moyse D, Blouin E, Guillet G, Léonard F, Knol AC. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012 Feb;148(2):182-6.[PMID: 22004878]
14. Wilson SS, Wiens ME, Smith JG Antiviral mechanisms of human defensins. J Mol Biol. 2013 Dec 13;425(24):4965-80. [PMID: 24095897]
15. Abe S, Miura K, Kinoshita A, Mishima H, Miura S, Yamasaki K, Hasegawa Y, Higashijima A, Jo O, Sasaki K, Yoshida A, Yoshiura K, Masuzaki H. Copy number variation of the antimicrobial-gene, defensin beta 4, is associated with susceptibility to cervical cancer. J Hum Genet. 2013 May;58(5):250-3.[PMID: 23466823]
16. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, Ma D, Lv D, Wen Y, Qu T, Chen M, Sun M, Shen Y, Zhang X. Gammasecretase gene mutations in familial acne inversa. Science. 2010 Nov 19;330(6007):1065.[PMID: 20929727]
17. Melnik BC, Plewig G. Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa). Br J Dermatol. 2013 Apr;168(4):876-8.[PMID: 23020871]
18. Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol 2013;22:172-77.
19. Chandramohan K, Mathews A, Kurian A, Thomas S, Ramachandran K. Squamous cell carcinoma arising from perineal lesion in a familial case of Hidradenitis suppurativa. Int Wound J. 2009 Apr;6(2):141-4.[PMID: 19432663]
20. Rothenberg SM, Ellisen LW. The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest. 2012 Jun 1;122(6):1951-7.[PMID: 22833868]
21. O'Donnell S, Murphy S, Anwar MM, O'Sullivan M, Breslin N, O'Connor HJ, Ryan BM, O'Morain CA. Safety of infliximab in 10 years of clinical practice. Eur J Gastroenterol Hepatol. 2011 Jul;23(7):603-6.[PMID: 21602689]
22. Faurschou A. Role of tumor necrosis factor-α in the regulation of keratinocyte cell cycle and DNA repair after ultraviolet-B radiation. Dan Med Bull. 2010 Oct;57(10):B4179.[PMID: 21040686]
23. Rahman N, Healy C, Flint SR, Stassen LF. Cautionary note: a possible association between oral squamous cell carcinoma and tumor necrosis factor antagonists; need for oral screening. J Clin Rheumatol. 2010 Jun;16(4):197-9.[PMID: 20511984]
24. Engel SH, Hullar TE, Adkins DR, Thorstad WL, Sunwoo JB. Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma. Laryngoscope. 2008 Mar;118(3):450-2.[PMID: 18090867]
25. Maalouf E, Faye O, Poli F, Cosnes A, Revuz J. Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab. Ann Dermatol Venereol. 2006 May;133(5 Pt 1):473-4.[PMID: 16760840]
26. Esser AC, Abril A, Fayne S, Doyle JA. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol. 2004 May;50(5 Suppl):S75-7.[PMID: 15097933]